IRVING, Texas, Nov. 1 /PRNewswire-FirstCall/ -- Carrington Laboratories, Inc. , a research-based, biopharmaceutical and consumer products company, will hold its quarterly conference call to discuss third quarter results on Thursday, November 2, 2006, at 4:30 p.m. Eastern Time (3:30 p.m. Central Time). Third quarter unaudited financial results will be released earlier the same day.
Investors are invited to listen to the conference call by dialing 800-510- 9691 in the US or 617-614-3453 internationally. The pass code is 74163928. The call is also being web cast by CCBN and can be accessed at Carrington’s web site at http://www.carringtonlabs.com.
The webcast is also being distributed through the Thomson StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call at http://www.fulldisclosure.com, Thomson/CCBN’s individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson’s password-protected event management site, StreetEvents (www.streetevents.com).
About Carrington
Carrington Laboratories, Inc. is an ISO 9001-certified, research-based biopharmaceutical company currently utilizing naturally-occurring complex carbohydrates to:
* manufacture and market products for mucositis, radiation dermatitis, wound and oral care; * manufacture and market the nutraceutical and cosmetic raw materials Manapol(R) and Hydrapol(TM); and, * market consumer products under various brands.
Carrington Laboratories, Inc.
CONTACT: Maria Mitchell of Carrington Laboratories, Inc., +1-972-518-1300, or mmitchell@carringtonlabs.com
